OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617
Andrea Schaefer-Schuler, Caroline Burgard, Arne Blickle, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 1829-1840
Open Access | Times Cited: 16
Andrea Schaefer-Schuler, Caroline Burgard, Arne Blickle, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 1829-1840
Open Access | Times Cited: 16
Showing 16 citing articles:
From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Deya’ Aldeen Sweedat, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1974-1974
Open Access | Times Cited: 5
Akram Al‐Ibraheem, Ahmed Saad Abdlkadir, Deya’ Aldeen Sweedat, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1974-1974
Open Access | Times Cited: 5
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer
Evangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
Materials (2025) Vol. 18, Iss. 2, pp. 248-248
Open Access
Evangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
Materials (2025) Vol. 18, Iss. 2, pp. 248-248
Open Access
Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review
Tahani O. Alkahtani
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Tahani O. Alkahtani
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Overview of the Impact of PSMA PET on the Management of Prostate Cancer Patients
Jinyu Zhang, Xin Dai, Xinyi Ren, et al.
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 169-189
Open Access
Jinyu Zhang, Xin Dai, Xinyi Ren, et al.
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 169-189
Open Access
Radiotheranostic landscape: A review of clinical and preclinical development
Huyen Tran, Aiko Yamaguchi, H. Charles Manning
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Huyen Tran, Aiko Yamaguchi, H. Charles Manning
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177
František Trejtnar, Pavel Bárta, Ján Kozempel, et al.
Nuclear Medicine and Biology (2025) Vol. 144-145, pp. 108998-108998
Closed Access
František Trejtnar, Pavel Bárta, Ján Kozempel, et al.
Nuclear Medicine and Biology (2025) Vol. 144-145, pp. 108998-108998
Closed Access
Is161Tb Really Happening?
Grace Kong, James Buteau, Michael S. Hofman
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 5, pp. 686-687
Open Access | Times Cited: 3
Grace Kong, James Buteau, Michael S. Hofman
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 5, pp. 686-687
Open Access | Times Cited: 3
New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate Cancer
Kévin Hébert, Paul Bodin-Cufi, Cyril Fersing, et al.
European Urology Focus (2024) Vol. 10, Iss. 4, pp. 514-517
Open Access | Times Cited: 3
Kévin Hébert, Paul Bodin-Cufi, Cyril Fersing, et al.
European Urology Focus (2024) Vol. 10, Iss. 4, pp. 514-517
Open Access | Times Cited: 3
Terbium sisters: current development status and upscaling opportunities
A. N. Moiseeva, Chiara Favaretto, Zeynep Talip, et al.
Frontiers in Nuclear Medicine (2024) Vol. 4
Open Access | Times Cited: 3
A. N. Moiseeva, Chiara Favaretto, Zeynep Talip, et al.
Frontiers in Nuclear Medicine (2024) Vol. 4
Open Access | Times Cited: 3
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Ahmed Saad Abdlkadir, Alaa Abufara, Akram Al‐Ibraheem
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 6, pp. 381-382
Closed Access | Times Cited: 2
Ahmed Saad Abdlkadir, Alaa Abufara, Akram Al‐Ibraheem
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 6, pp. 381-382
Closed Access | Times Cited: 2
Palladium-103 (103Pd/103mRh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to 177Lu and 161Tb
Elif Hindié, Alexandre Larouze, Mario Alcocer-Ávila, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4318-4330
Open Access | Times Cited: 2
Elif Hindié, Alexandre Larouze, Mario Alcocer-Ávila, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4318-4330
Open Access | Times Cited: 2
PSMA-based therapeutics for prostate cancer
Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Aggeliki Leventi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1405-1419
Closed Access | Times Cited: 2
Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Aggeliki Leventi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1405-1419
Closed Access | Times Cited: 2
Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review
Ahmed Saad Abdlkadir, Florian Rosar, Amir Reza Jalilian, et al.
Nuclear Medicine and Molecular Imaging (2024) Vol. 59, Iss. 1, pp. 50-61
Closed Access | Times Cited: 2
Ahmed Saad Abdlkadir, Florian Rosar, Amir Reza Jalilian, et al.
Nuclear Medicine and Molecular Imaging (2024) Vol. 59, Iss. 1, pp. 50-61
Closed Access | Times Cited: 2
Review on the Increasing Role for PSMA-Based Radioligand Therapy in Prostate Cancer
Finn Edler von Eyben, Irene Virgolini, Richard P. Baum
Cancers (2024) Vol. 16, Iss. 14, pp. 2520-2520
Open Access | Times Cited: 1
Finn Edler von Eyben, Irene Virgolini, Richard P. Baum
Cancers (2024) Vol. 16, Iss. 14, pp. 2520-2520
Open Access | Times Cited: 1
Lanthanides and their complexes/nanoparticles: A review of cancer diagnosis, therapeutics, toxicity considerations, and clinical trials
Tatenda Madanhire, Louis‐Charl C. Coetzee, Adedapo S. Adeyinka, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106561-106561
Closed Access | Times Cited: 1
Tatenda Madanhire, Louis‐Charl C. Coetzee, Adedapo S. Adeyinka, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106561-106561
Closed Access | Times Cited: 1
Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+
Ina Hierlmeier, Nadia Marino, Moritz-Valentin Schreck, et al.
Inorganic Chemistry (2024)
Closed Access
Ina Hierlmeier, Nadia Marino, Moritz-Valentin Schreck, et al.
Inorganic Chemistry (2024)
Closed Access
